Express Scripts Is Under More Scrutiny
November 01, 2016 at 14:40 PM EDT
Express Scripts Holding Company (NASDAQ: ESRX) failed to turn over nearly $1.5 million in drug manufacturer rebates over a four-year ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.